Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 24062619)

Published in Neurobehav HIV Med on August 10, 2010

Authors

Allison J Applebaum1, Jacqueline R Bullis, Lara N Traeger, Conall O'cleirigh, Michael W Otto, Mark H Pollack, Steven A Safren

Author Affiliations

1: Behavioral Medicine service, Massachusetts General Hospital, Boston University, Boston, Massachusetts, USA.

Associated clinical trials:

Digital Intervention to Treat Anxiety and Depression Among Persons Receiving Treatment for Opioid Use Disorder | NCT05047627

Articles cited by this

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11

A new depression scale designed to be sensitive to change. Br J Psychiatry (1979) 36.40

The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat (1992) 29.45

The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry (1998) 8.38

Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry (2001) 7.30

Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry (2004) 6.80

Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatry (2001) 5.22

Methadone maintenance in primary care: a randomized controlled trial. JAMA (2001) 2.35

The descriptive epidemiology of commonly occurring mental disorders in the United States. Annu Rev Public Health (2008) 2.32

Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J Anal Toxicol (2002) 2.10

Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the Southeastern United States. J Acquir Immune Defic Syndr (2006) 2.01

Health-related quality of life among people with HIV disease: results from the Multicenter AIDS Cohort Study. Qual Life Res (2000) 1.63

Depression among needle exchange program and methadone maintenance clients. J Subst Abuse Treat (2000) 1.58

Factors associated with lapses to heroin use during methadone maintenance. Drug Alcohol Depend (1998) 1.52

Do trauma history and PTSD symptoms influence addiction relapse context? Drug Alcohol Depend (2007) 1.43

Major depression in patients with HIV/AIDS and substance abuse. AIDS Patient Care STDS (2007) 1.41

Heroin use during methadone maintenance treatment: the importance of methadone dose and cocaine use. Am J Public Health (1995) 1.40

Health-related quality of life of patients with HIV: impact of sociodemographic, clinical and psychosocial factors. Qual Life Res (2005) 1.39

Re-estimating the prevalence of psychiatric disorders in a nationally representative sample of persons receiving care for HIV: results from the HIV Cost and Services Utilization Study. Int J Methods Psychiatr Res (2002) 1.39

Comparing individual therapies for personality disordered opioid dependent patients. J Pers Disord (2007) 1.34

Social anxiety as a risk factor for unprotected intercourse among gay and bisexual male youth. AIDS Behav (2005) 1.24

Illicit drug use and HIV treatment outcomes in a US cohort. AIDS (2008) 1.24

Posttraumatic stress disorder: an empirical evaluation of core assumptions. Clin Psychol Rev (2007) 1.24

Can induced moods trigger drug-related responses in opiate abuse patients? J Subst Abuse Treat (1994) 1.24

Psychopathology in male and female intravenous drug users with and without HIV infection. Am J Psychiatry (1994) 1.22

Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord (2006) 1.22

Psychopathology in male and female HIV-positive and negative injecting drug users: longitudinal course over 3 years. AIDS (1997) 1.21

Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. Psychosom Med (2008) 1.19

The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions. Subst Use Misuse (2010) 1.18

Health-related quality of life in HIV-infected patients: the role of substance use. AIDS Patient Care STDS (2008) 1.17

Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence. Drug Alcohol Depend (2007) 1.17

The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br J Clin Pharmacol (2001) 1.16

Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy (2008) 1.16

On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users. Int J Legal Med (2000) 1.15

Gender and comorbidity among individuals with opioid use disorders in the NESARC study. Addict Behav (2009) 1.15

Social networks and methadone treatment outcome: the costs and benefits of social ties. Am J Drug Alcohol Abuse (1993) 1.11

Structural validity of MADRS during antidepressant treatment. Int Clin Psychopharmacol (1995) 1.06

Substance use after residential treatment among individuals with co-occurring disorders: the role of anxiety/depressive symptoms and trauma exposure. Psychol Addict Behav (2009) 1.05

Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder. J Anxiety Disord (2004) 1.01

Methadone maintenance dosing guideline for opioid dependence, a literature review. J Addict Dis (2010) 0.98

Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials. Am J Drug Alcohol Abuse (2009) 0.96

High dose versus moderate dose methadone maintenance: is there a better outcome? J Addict Dis (2009) 0.95

Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend (2007) 0.94

Social anxiety and HIV transmission risk among HIV-seropositive male patients. AIDS Patient Care STDS (2008) 0.94

Predictors of injecting and injecting risk-taking behaviour among methadone-maintenance clients. Addiction (1994) 0.92

Treatment process and relapse to opioid use during methadone maintenance. Am J Drug Alcohol Abuse (1994) 0.90

Relapse determinants reported by men treated for alcohol addiction: the prominence of depressed mood. J Subst Abuse Treat (2000) 0.88

Anxiety disorders moderate the association between externalizing problems and substance use disorders: data from the National Comorbidity Survey-Revised. J Anxiety Disord (2008) 0.88

Effects of receiving additional off-site services on abstinence from illicit drug use among men on methadone: a longitudinal study. Eval Program Plann (2009) 0.84

Psychosocial predictors of the onset of anxiety disorders in women: results from a prospective 3-year longitudinal study. J Anxiety Disord (2009) 0.84

Exploratory analysis of the association between new-type drug use and sexual transmission of HIV in China. Am J Drug Alcohol Abuse (2010) 0.82

Social anxiety and assertiveness: a comparison of the correlations in phobic and college student samples. Behav Res Ther (1982) 0.79

Developing therapies for depression in drug dependence: results of a stage 1 therapy study. Am J Drug Alcohol Abuse (2008) 0.78

Sense of coherence as a stable predictor for methadone maintenance treatment (MMT) outcome. J Psychoactive Drugs (2009) 0.78

Review: methadone increases retention and reduces heroin use compared with non-pharmacological maintenance. Evid Based Ment Health (2010) 0.78

Stages and processes of change as predictors of drug use among methadone maintenance patients. Exp Clin Psychopharmacol (1997) 0.78

Articles by these authors

Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med (2007) 8.07

A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry (2008) 6.24

Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr (2009) 5.48

Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care (2008) 4.33

Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav (2007) 4.07

Risk for new onset of depression during the menopausal transition: the Harvard study of moods and cycles. Arch Gen Psychiatry (2006) 3.70

Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2006) 3.66

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60

Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis. J Acquir Immune Defic Syndr (2011) 3.54

Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care (2007) 3.40

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38

A double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder. Am J Psychiatry (2014) 3.27

A randomized controlled trial of cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected individuals. Health Psychol (2009) 3.26

Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry (2005) 3.19

Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDS (2005) 2.92

Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry (2006) 2.85

Augmentation of exposure therapy with D-cycloserine for social anxiety disorder. Arch Gen Psychiatry (2006) 2.77

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa. PLoS Med (2013) 2.44

Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43

Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA (2010) 2.30

A review of HIV antiretroviral adherence and intervention studies among HIV-infected youth. Top HIV Med (2009) 2.24

Childhood sexual abuse is highly associated with HIV risk-taking behavior and infection among MSM in the EXPLORE Study. J Acquir Immune Defic Syndr (2009) 2.17

Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Arch Intern Med (2004) 2.16

Efficacy of d-cycloserine for enhancing response to cognitive-behavior therapy for panic disorder. Biol Psychiatry (2009) 2.09

Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther (2005) 2.08

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2004) 2.04

Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic review. J Clin Psychiatry (2013) 2.00

Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry (2005) 1.97

D-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder. Am J Psychiatry (2013) 1.94

Cognitive behavioral therapy for adherence and depression (CBT-AD) in HIV-infected injection drug users: a randomized controlled trial. J Consult Clin Psychol (2012) 1.94

Unseen and unheard: predictors of sexual risk behavior and HIV infection among men who have sex with men in Chennai, India. AIDS Educ Prev (2009) 1.83

Cross-cultural differences in somatic presentation in patients with generalized anxiety disorder. J Nerv Ment Dis (2006) 1.76

A functional MRI study of amygdala responses to angry schematic faces in social anxiety disorder. Depress Anxiety (2008) 1.68

HIV in Indian MSM: reasons for a concentrated epidemic & strategies for prevention. Indian J Med Res (2011) 1.67

"We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine. AIDS Care (2010) 1.60

Depressive symptoms, utilization of mental health care, substance use and sexual risk among young men who have sex with men in EXPLORE: implications for age-specific interventions. AIDS Behav (2008) 1.59

Prospective associations between HIV-related stigma, transmission risk behaviors, and adverse mental health outcomes in men who have sex with men. Ann Behav Med (2011) 1.55

A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. J Psychiatr Res (2012) 1.50

A review of treating depression in diabetes: emerging findings. Psychosomatics (2011) 1.49

The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV. AIDS Patient Care STDS (2008) 1.48

A meta-analysis of the magnitude of biased attention in depression. Depress Anxiety (2010) 1.47

Reducing anxiety sensitivity with exercise. Depress Anxiety (2008) 1.46

D-cycloserine deters reacquisition of cocaine self-administration by augmenting extinction learning. Neuropsychopharmacology (2010) 1.46

Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors. Sci Pract Perspect (2007) 1.44

Baseline predictors of serious adverse events at one year among patients with bipolar disorder in STEP-BD. Psychiatr Serv (2005) 1.43

Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV. J Acquir Immune Defic Syndr (2010) 1.38

Behavioral aspects of HIV care: adherence, depression, substance use, and HIV-transmission behaviors. Infect Dis Clin North Am (2007) 1.35

Street workers and internet escorts: contextual and psychosocial factors surrounding HIV risk behavior among men who engage in sex work with other men. J Urban Health (2008) 1.35

Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav (2008) 1.35

Shared Variance among Self-Report and Behavioral Measures of Distress Intolerance. Cognit Ther Res (2011) 1.33

Prevention of missing data in clinical research studies. Biol Psychiatry (2006) 1.32

Discussion of sexual risk behavior in HIV care is infrequent and appears ineffectual: a mixed methods study. AIDS Behav (2011) 1.32

Sexual behaviors of individuals with HIV living in South India: a qualitative study. AIDS Educ Prev (2007) 1.31

Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry (2003) 1.31

Review of treatment studies of depression in HIV. Top HIV Med (2006) 1.30

Suicidality, clinical depression, and anxiety disorders are highly prevalent in men who have sex with men in Mumbai, India: findings from a community-recruited sample. Psychol Health Med (2011) 1.29

HIV risk and social networks among male-to-female transgender sex workers in Boston, Massachusetts. J Assoc Nurses AIDS Care (2009) 1.28

Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. Bipolar Disord (2006) 1.28

Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry (2005) 1.28

Effect of acute posttrauma propranolol on PTSD outcome and physiological responses during script-driven imagery. CNS Neurosci Ther (2011) 1.27

Cognitive behavioral therapy for substance use disorders. Psychiatr Clin North Am (2010) 1.26

Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry (2013) 1.26

Mental health: a focus on stress, coping, and mental illness as it relates to treatment retention, adherence, and other health outcomes. Curr HIV/AIDS Rep (2011) 1.26

D-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia. Biol Psychiatry (2013) 1.26

Panic attacks and risk of incident cardiovascular events among postmenopausal women in the Women's Health Initiative Observational Study. Arch Gen Psychiatry (2007) 1.24

Stressful or traumatic life events, post-traumatic stress disorder (PTSD) symptoms, and HIV sexual risk taking among men who have sex with men. AIDS Care (2009) 1.23

Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep (2014) 1.23

Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav (2011) 1.22

Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev (2007) 1.22

Counselor- versus provider-based HIV screening in the emergency department: results from the universal screening for HIV infection in the emergency room (USHER) randomized controlled trial. Ann Emerg Med (2011) 1.21

Risk factors for missed HIV primary care visits among men who have sex with men. J Behav Med (2011) 1.21

Let's get physical: a contemporary review of the anxiolytic effects of exercise for anxiety and its disorders. Depress Anxiety (2013) 1.21

Resilience: research evidence and conceptual considerations for posttraumatic stress disorder. Depress Anxiety (2007) 1.21

Posttraumatic stress disorder symptoms following media exposure to tragic events: impact of 9/11 on children at risk for anxiety disorders. J Anxiety Disord (2007) 1.19

Prefrontal and temporal gray matter density decreases in opiate dependence. Psychopharmacology (Berl) (2005) 1.19

The serotonin transporter gene and risk for alcohol dependence: a meta-analytic review. Drug Alcohol Depend (2010) 1.19

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam. Arch Gen Psychiatry (2005) 1.19

The effect of psychosocial syndemic production on 4-year HIV incidence and risk behavior in a large cohort of sexually active men who have sex with men. J Acquir Immune Defic Syndr (2015) 1.19

The influence of stigma on HIV risk behavior among men who have sex with men in Chennai, India. AIDS Care (2012) 1.18

Substance use among HIV-infected patients engaged in primary care in the United States: findings from the Centers for AIDS Research Network of Integrated Clinical Systems cohort. Am J Public Health (2013) 1.18

Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older premenopausal women. The Harvard Study of Moods and Cycles. J Affect Disord (2002) 1.18

A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design. J Trauma Stress (2005) 1.18

Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry (2005) 1.18

Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS (2010) 1.17

Treatment of pharmacotherapy-refractory posttraumatic stress disorder among Cambodian refugees: a pilot study of combination treatment with cognitive-behavior therapy vs sertraline alone. Behav Res Ther (2003) 1.17

Validity of medication adherence self-reports in adults with type 2 diabetes. Diabetes Care (2012) 1.16

Polysubstance use and HIV/STD risk behavior among Massachusetts men who have sex with men accessing Department of Public Health mobile van services: implications for intervention development. AIDS Patient Care STDS (2008) 1.16

Sexual orientation and anabolic-androgenic steroids in U.S. adolescent boys. Pediatrics (2014) 1.16

Lost opportunities to reduce periconception HIV transmission: safer conception counseling by South African providers addresses perinatal but not sexual HIV transmission. J Acquir Immune Defic Syndr (2014) 1.15

Whoonga: potential recreational use of HIV antiretroviral medication in South Africa. AIDS Behav (2014) 1.15